Facilitated Uptake of a Bioactive Metabolite of Maritime Pine Bark Extract (Pycnogenol) into Human Erythrocytes

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Kurlbaum, Max ^a   Mülek, Melanie ^a   Högger, Petra ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; DELTA (3,4 DIHYDROXYPHENYL) GAMMA VALEROLACTONE; GLUCOSE TRANSPORTER 1; GLUTATHIONE; PYCNOGENOL; UNCLASSIFIED DRUG; FLAVONOID; GLUCOSE; PLANT EXTRACT; PYCNOGENOLS;

ARTICLE; BINDING AFFINITY; BIOACCUMULATION; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG BINDING; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG TRANSPORT; ERYTHROCYTE; HUMAN; HUMAN CELL; BARK; CHEMISTRY; DRUG EFFECTS; HEMOLYSIS; MASS SPECTROMETRY; METABOLISM; OXIDATIVE STRESS; PINE;

PINUS PINASTER;

ANTIOXIDANTS; ERYTHROCYTES; FLAVONOIDS; GLUCOSE; HEMOLYSIS; HUMANS; MASS SPECTROMETRY; OXIDATIVE STRESS; PINUS; PLANT BARK; PLANT EXTRACTS;

EID: 84876953809     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063197     Document Type: Article

References (56)

1. Maritime Pine Extract (2011) In:United States Pharmacopeia. ed. Rockville: United States Pharmacopeial Convention, Inc. 1196-1197.
2. Packer L, Rimbach G, Virgili F, (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27: 704-724.
3. Rohdewald P, (2002) A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40: 158-168.
4. Maimoona A, Naeem I, Saddiqe Z, Jameel K, (2011) A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J Ethnopharmacol 133: 261-277.
5. Manach C, Williamson G, Morand C, Scalbert A, Remesy C, (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S.
6. Grimm T, Skrabala R, Chovanova Z, Muchova J, Sumegova K, et al. (2006) Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers. BMC Clin Pharmacol 6: 4.
7. Das NP, (1971) Studies on flavonoid metabolism. Absorption and metabolism of (+)-catechin in man. Biochem Pharmacol 20: 3435-3445.
8. Düweler KG, Rohdewald P, (2000) Urinary metabolites of French maritime pine bark extract in humans. Pharmazie 55: 364-368.
9. Li C, Lee MJ, Sheng S, Meng X, Prabhu S, et al. (2000) Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13: 177-184.
10. Li C, Meng X, Winnik B, Lee MJ, Lu H, et al. (2001) Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chem Res Toxicol 14: 702-707.
11. Grimm T, Schäfer A, Högger P, (2004) Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (pycnogenol). Free Radic Biol Med 36: 811-822.
12. Biasutto L, Marotta E, Garbisa S, Zoratti M, Paradisi C, (2010) Determination of quercetin and resveratrol in whole blood - implications for bioavailability studies. Molecules 15: 6570-6579.
13. Uhlenhut K, Högger P, (2012) Facilitated cellular uptake and suppression of inducible nitric oxide synthase by a metabolite of maritime pine bark extract (Pycnogenol). Free Radic Biol Med 53: 305-313.
14. Highley MS, De Bruijn EA, (1996) Erythrocytes and the transport of drugs and endogenous compounds. Pharm Res 13: 186-195.
15. Hinderling PH, (1997) Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol Rev 49: 279-295.
16. Kurlbaum M, Högger P, (2011) Plasma protein binding of polyphenols from maritime pine bark extract (USP). J Pharm Biomed Anal 54: 127-132.
17. Rappold M (2010) Synthese von d-(3′,4′-Dihydroxyphenyl)-g-valerolacton und Derivaten sowie die Enantiomerentrennung der Zwischenstufen an chiraler Phase und Synthese des-Azidoanilin-8-azidoadenosintriphosphat-Lithiumsalzes [Diploma thesis]. Würzburg: Universität Würzburg. p. 11-21.
18. Galbraith DA, Watts DC, (1980) Changes in some cytoplasmic enzymes from red cells fractionated into age groups by centrifugation in Ficoll/Triosil gradients. Comparison of normal humans and patients with Duchenne muscular dystrophy. Biochem J 191: 63-70.
19. Yu S, Li S, Yang H, Lee F, Wu JT, et al. (2005) A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Rapid Commun Mass Spectrom 19: 250-254.
20. Salauze DD, (1994) In vitro assessement of the haemolytic potential of candidate drugs. Comp Haematol Int 4: 34-36.
21. Leitch JM, Carruthers A, (2009) alpha- and beta-monosaccharide transport in human erythrocytes. Am J Physiol Cell Physiol 296: C151-161.
22. Sana TR, Waddell K, Fischer SM, (2008) A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome. J Chromatogr B Analyt Technol Biomed Life Sci 871: 314-321.
23. Baillie TA, Davis MR, (1993) Mass spectrometry in the analysis of glutathione conjugates. Biol Mass Spectrom 22: 319-325.
24. Castro-Perez J, Plumb R, Liang L, Yang E, (2005) A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. Rapid Commun Mass Spectrom 19: 798-804.
25. Williamson G, Manach C, (2005) Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 81: 243S-255S.
26. Grimm T, Chovanova Z, Muchova J, Sumegova K, Liptakova A, et al. (2006) Inhibition of NF-kappaB activation and MMP-9 secretion by plasma of human volunteers after ingestion of maritime pine bark extract (Pycnogenol). J Inflamm (Lond) 3: 1.
27. Koren E, Kohen R, Ginsburg I, (2010) Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp Biol Med (Maywood) 235: 689-699.
28. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, et al. (1985) Sequence and structure of a human glucose transporter. Science 229: 941-945.
29. Mueckler M, (1994) Facilitative glucose transporters. Eur J Biochem 219: 713-725.
30. Perez A, Ojeda P, Ojeda L, Salas M, Rivas CI, et al. (2011) Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins. Biochemistry 50: 8834-8845.
31. Garcia CK, Brown MS, Pathak RK, Goldstein JL, (1995) cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1. J Biol Chem 270: 1843-1849.
32. Raja MM, Tyagi NK, Kinne RK, (2003) Phlorizin recognition in a C-terminal fragment of SGLT1 studied by tryptophan scanning and affinity labeling. J Biol Chem 278: 49154-49163.
33. Fan HT, Morishima S, Kida H, Okada Y, (2001) Phloretin differentially inhibits volume-sensitive and cyclic AMP-activated, but not Ca-activated, Cl(-) channels. Br J Pharmacol 133: 1096-1106.
34. Yang B, Ma T, Verkman AS, (2001) Erythrocyte water permeability and renal function in double knockout mice lacking aquaporin-1 and aquaporin-3. J Biol Chem 276: 624-628.
35. Martial S, Olives B, Abrami L, Couriaud C, Bailly P, et al. (1996) Functional differentiation of the human red blood cell and kidney urea transporters. Am J Physiol 271: F1264-1268.
36. Kalsi KK, Baker EH, Medina RA, Rice S, Wood DM, et al. (2008) Apical and basolateral localisation of GLUT2 transporters in human lung epithelial cells. Pflugers Arch 456: 991-1003.
37. Martin HJ, Kornmann F, Fuhrmann GF, (2003) The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chem Biol Interact 146: 225-235.
38. Thorens B, (1996) Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 270: G541-553.
39. Montel-Hagen A, Sitbon M, Taylor N, (2009) Erythroid glucose transporters. Curr Opin Hematol 16: 165-172.
40. Lagerquist Hagglund C, Lundahl P, (2003) Centrifugal and chromatographic analyses of tryptophan and tyrosine uptake by red blood cells and GLUT1 proteoliposomes with permeability estimates and observations on dihydrocytochalasin B. J Biochem Biophys Methods. 55: 127-140.
41. Zhang JZ, Hayashi H, Ebina Y, Prohaska R, Ismail-Beigi F, (1999) Association of stomatin (band 7.2b) with Glut1 glucose transporter. Arch Biochem Biophys 372: 173-178.
42. Zhang JZ, Abbud W, Prohaska R, Ismail-Beigi F, (2001) Overexpression of stomatin depresses GLUT-1 glucose transporter activity. Am J Physiol Cell Physiol 280: C1277-1283.
43. Montel-Hagen A, Kinet S, Manel N, Mongellaz C, Prohaska R, et al. (2008) Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell. 132: 1039-1048.
44. Cunningham P, Afzal-Ahmed I, Naftalin RJ, (2006) Docking studies show that D-glucose and quercetin slide through the transporter GLUT1. J Biol Chem 281: 5797-5803.
45. Schrijvers D, (2003) Role of red blood cells in pharmacokinetics of chemotherapeutic agents. Clin Pharmacokinet 42: 779-791.
46. Pardridge WM, Boado RJ, Farrell CR, (1990) Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization. J Biol Chem 265: 18035-18040.
47. Tietze F, (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27: 502-522.
48. Marcus CJ, Habig WH, Jakoby WB, (1978) Glutathione transferase from human erythrocytes. Nonidentity with the enzymes from liver. Arch Biochem Biophys 188: 287-293.
49. Awasthi YC, Misra G, Rassin DK, Srivastava SK, (1983) Detoxification of xenobiotics by glutathione S-transferases in erythrocytes: the transport of the conjugate of glutathione and 1-chloro-2,4-dinitrobenzene. Br J Haematol 55: 419-425.
50. Awad HM, Boersma MG, Boeren S, Van Bladeren PJ, Vervoort J, et al. (2003) Quenching of quercetin quinone/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation. Chem Res Toxicol 16: 822-831.
51. Jacobs H, Moalin M, van Gisbergen MW, Bast A, van der Vijgh WJ, et al. (2011) An essential difference in the reactivity of the glutathione adducts of the structurally closely related flavonoids monoHER and quercetin. Free Radic Biol Med doi:10.1016/j.freeradbiomed.2011.09.013.
52. van Bladeren PJ, (2000) Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129: 61-76.
53. Boots AW, Balk JM, Bast A, Haenen GR, (2005) The reversibility of the glutathionyl-quercetin adduct spreads oxidized quercetin-induced toxicity. Biochem Biophys Res Commun 338: 923-929.
54. Hapner CD, Deuster P, Chen Y, (2010) Inhibition of oxidative hemolysis by quercetin, but not other antioxidants. Chem Biol Interact 186: 275-279.
55. Sugano K, Kansy M, Artursson P, Avdeef A, Bendels S, et al. (2010) Coexistence of passive and carrier-mediated processes in drug transport. Nat Rev Drug Discov 9: 597-614.
56. Alonso GL, Gonzalez DA, (2007) In silico kinetic study of the glucose transporter. J Biol Phys 33: 485-498.